XPhyto Therapeutics Corp.: XPhyto Provides Updated Comments on Promotional and Marketing Activity
XPhyto Therapeutics Corp. (
XPhyto" or the "
Company") at the request of IIROC and the Canadian Securities Exchange (the "
CSE") is providing additional comments to its news release and list of third-party providers dated January 22, 2021 with regards to recent promotional and investor relations activity ("
Promotional Activity") provided by said third-parties, in particular a newsletter published by WallStreetAlerts, on behalf of the Company.
The Company reminds investors that the best source for full disclosure about the company is the company itself, SEDAR or CSE profile pages for regulatory filings and news releases. The Company acknowledges that prior to the date of this news release, XPhyto did not comply with the CSE requirements to complete and post Form 10 Notices of Proposed Significant Transactions disclosing its contracts with the third-party providers. The Company has now completed and posted the required forms to the CSE and will continue to do so in the future.